The selection of an appropriate dose of a given antibiotic for a neonate not only requires knowledge of the drug’s basic pharmacokinetic (PK) and pharmacodynamic (PD) properties but also the profound effects that organ development might have on the volume of distribution and clearance, both of which may affect the PK/PD of a drug. Interest has grown in alternative antibiotic dosing strategies that are better aligned with the antibiotic’s PK and PD properties. These strategies should be used in conjunction with minimum inhibitory concentration measurements and therapeutic drug monitoring to measure their potential success. They can also guide the clinician in tailoring the delivery of antibiotics to suit an individual patient’s needs. Model-informed precision dosing, such as Bayesian forecasting dosing software (which incorporates PK/PD population models), may be utilized to optimize antibiotic exposure in neonatal populations. Consequently, optimizing the antibiotic dose and exposure in each newborn requires expertise in different fields. It drives the collaboration of physicians together with lab technicians and quantitative clinical pharmacologists.

Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates / Regazzi, M.; Berardi, A.; Picone, S.; Tzialla, C.. - In: ANTIBIOTICS. - ISSN 2079-6382. - 12:12(2023), pp. 1-13. [10.3390/antibiotics12121747]

Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates

Berardi A.;
2023

Abstract

The selection of an appropriate dose of a given antibiotic for a neonate not only requires knowledge of the drug’s basic pharmacokinetic (PK) and pharmacodynamic (PD) properties but also the profound effects that organ development might have on the volume of distribution and clearance, both of which may affect the PK/PD of a drug. Interest has grown in alternative antibiotic dosing strategies that are better aligned with the antibiotic’s PK and PD properties. These strategies should be used in conjunction with minimum inhibitory concentration measurements and therapeutic drug monitoring to measure their potential success. They can also guide the clinician in tailoring the delivery of antibiotics to suit an individual patient’s needs. Model-informed precision dosing, such as Bayesian forecasting dosing software (which incorporates PK/PD population models), may be utilized to optimize antibiotic exposure in neonatal populations. Consequently, optimizing the antibiotic dose and exposure in each newborn requires expertise in different fields. It drives the collaboration of physicians together with lab technicians and quantitative clinical pharmacologists.
2023
12
12
1
13
Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates / Regazzi, M.; Berardi, A.; Picone, S.; Tzialla, C.. - In: ANTIBIOTICS. - ISSN 2079-6382. - 12:12(2023), pp. 1-13. [10.3390/antibiotics12121747]
Regazzi, M.; Berardi, A.; Picone, S.; Tzialla, C.
File in questo prodotto:
File Dimensione Formato  
antibiotics-12-01747.pdf

Open access

Tipologia: VOR - Versione pubblicata dall'editore
Dimensione 529.74 kB
Formato Adobe PDF
529.74 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1366520
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact